Invisible indoor threats: emerging household contaminants and their growing risks to human health
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Dec-2025 14:11 ET (21-Dec-2025 19:11 GMT/UTC)
A team of researchers led by Karina Xavier has uncovered a promising new live biotherapeutic agent that may redefine how the medical field approaches microbiota-based therapies. Their study, published in Nature Communications, demonstrates that a harmless strain of Klebsiella – originally discovered by chance in laboratory experiments – can eliminate infections and reduce gut inflammation in mouse models of inflammatory bowel disease (IBD).
University Hospitals CEO, Cliff Megerian, MD, FACS, was honored to receive the Sam Miller Goodness Award by the Values-in-Action Foundation on Dec. 8, joining an inspiring lineup of honorees who shine their light throughout Northeast Ohio and contribute to making the community a better place to live. Each year, the Values-in-Action Foundation honors individuals who represent goodness, caring and respect beyond the norm.
Doctors treating seriously ill patients in an emergency setting may want to give the sedative etomidate, rather than ketamine, while placing a breathing tube, according to a randomized trial published Dec. 9 in the New England Journal of Medicine. The Randomized Trial of Sedative Choice for Intubation (RSI) is the first multicenter trial to demonstrate significant cardiovascular risks of high doses of ketamine (low blood pressure, arrhythmia), side effects that have not been well studied in the past.
Leslie M. Thompson, Donald Bren Professor of psychiatry and human behavior as well as neurobiology and behavior at the University of California, Irvine, has received an $11,999,933 grant from the California Institute for Regenerative Medicine for an unprecedented clinical trial of a novel neural stem cell therapy for Huntington’s disease.